The COVID-19 pandemic is an unprecedented time in global history and has many
emerging challenges and consequences. While much of the world was focused on the …

Background: Telemedicine, including video-, web-, and telephone-based interventions, is
used in adult and pediatric populations to deliver health care and communicate with …

The concerning toxicity associated with hydroxyurea (HU), an anticancer drug used in
cancer treatment, has spurred significant attention within the research community over the …

Objectives Sickle cell disease (SCD) leads to chronic and acute complications that require
specialised care to manage symptoms and optimise clinical results. The National Heart …

Sickle cell disease (SCD) is the most common genetic blood disorder in the world and
affects millions of people. With aging, patients encounter an increasing number of …

Individuals with sickle cell disease (SCD) experience neurocognitive decline, low
medication adherence, increased unemployment, and difficulty with instrumental activities of …

Hydroxyurea reduces sickle cell disease (SCD) complications, but medication adherence is
low. We tested 2 mobile health (mHealth) interventions targeting determinants of low …

Youth living with chronic sickle cell disease (SCD) pain are at risk for psychosocial distress
and high levels of pain catastrophizing that contribute to functional impairment. This study …

Hydroxyurea is an efficacious treatment for sickle cell disease (SCD), but adoption is low
among individuals with SCD. The objective of this study was to examine barriers to patients' …

After pediatric heart transplant, commitment to lifelong immunosuppression is crucial to
maintaining graft health. However, a review of the current literature surrounding adherence …